|
Multiple Sclerosis and Epstein-Barr Virus http://www.mercola.com/2000/aug/27/multiple_sclerosis_epstein_barr.htm
German researchers have demonstrated that there may be an association between
the Epstein-Barr Virus (EBV) reactivation and disease activity in Multiple
Sclerosis (MS) patients over time. 108 MS patients and 163 controls were
assessed for the prevalence of antibodies against herpes simplex virus type 1
(HSV-1), HSV-2, EBV, and cytomegalovirus (CMV). In contrast to the control
populations, antibodies against EBV were present in 100% of MS patients.
There was no significant differences between the groups for the other
viruses. 19 of the MS patients were then followed monthly for 1 year,
measuring active viral replication and it was noted that viral reactivation was
seen in 72.7% of patients with exacerbations of their MS symptoms. The
authors suggest that EBV might play an indirect role in MS as an activator of
the underlying disease process. This could therefore, have some clinical
significance in the treatment of this difficult condition. Neurology July
25, 2000; 55:178-84
Dr. Mercola's Comment: MS is a very challenging problem to treat. There
are no simple solutions. Usually mercury is a complicating factor. The mercury
tends to impair the immune system and allow infections like Epstein Barr worsen
the problem. Following a good diet is of course also key. Elimination of
milk and dairy is critical. Studies have shown that cow's milk consumption is
correlated with MS prevalence (Neuroepidemiology 1992;11:304-12,
Neuroepidemiology 1993;12:15-27). Collection of data from the autonomic
nervous system is one of the most sophisticated approaches that I am aware of to
learn what the underlying reasons for the cause of MS. Here are some other
avenues that might be useful as well: 1. Vitamin D Deficiency
- MS much more common in individuals with lower vitamin D levels and in
countries where people get less sunlight exposure. A previous article in the
newsletter showed a positive effect of sunlight exposure on MS. Maybe correcting
a vitamin D deficiency can halt progression? 2. Calcium AEP - Although I
don't know of any good studies on it, the late Dr. Nieper in Germany used it
extensively in his clinic and Dr. Robert Atkins in New York City claims that 85%
of his patients get positive results from it. Although there is an oral form
available, most physicians use an IV administration. I have not tried it yet but
might enter a clinical investigation with it in the near future. 3.
Electromagnetic Stimulation of the Pineal Gland - There is a Dr. Reuven Sandyk
in the NYC area who uses AC pulsed electromagnetic fields to stimulate the
pineal gland and he seems to get some very good results, although the treatment
is very expensive and must be done long-term. Due to the prohibitively expensive
equipment, Dr. Sandyk's clinic is probably the only place to receive this
treatment. 4. Alpha Lipoic Acid - A study from the Netherlands showed that
Lipoic acid is a non-specific scavenger of Reactive Oxygen Species and decreased
the phagocytosis of myelin by macrophages. Free radicals appear to play a
regulatory role in the destruction of myelin (Journal of Neuroimmunology 1998
Dec 1;92:67-75) 5. Progesterone - Progesterone has actually been shown in
animal studies to promote the formation of new myelin sheaths (Human
Reproduction 2000 Jun;15 Suppl 1:1-13, J Steroid Biochem Mol Biol 1999
Apr-Jun;69:97-107, Mult Scler 1997 Apr;3:105-12). I am not aware of any
clinicians using progesterone the treat MS patients, but if any of my readers
have any additional information on this, please e-mail me. Related Articles:
HERPES VIRUS MAY TRIGGER MULTIPLE SCLEROSIS Sunlight Exposure Beneficial
In Multiple Sclerosis Return To Table of Contents Issue #168
Return to Table of Contents #168
Print this Page E-mail to a Friend
Privacy/Security Current Newsletter Contact Info
This site is powered by the Northwoods Titan Content Management System
©Copyright 2005 Dr. Joseph Mercola. All Rights Reserved. This content
may be copied in full, with copyright, contact, creation and information intact,
without specific permission, when used only in a not-for-profit format. If any
other use is desired, permission in writing from Dr. Mercola is required.
Disclaimer: The entire contents of this website are based upon the opinions
of Dr. Mercola, unless otherwise noted. Individual articles are based upon the
opinions of the respective author, who retains copyright as marked. The
information on this website is not intended to replace a one-on-one relationship
with a qualified health care professional and is not intended as medical advice.
It is intended as a sharing of knowledge and information from the research and
experience of Dr. Mercola and his community. Dr. Mercola encourages you to make
your own health care decisions based upon your research and in partnership with
a qualified health care professional.
--~--~---------~--~----~------------~-------~--~----~
You received this message because you are subscribed to the Google Groups "MedicalConspiracies" group.
To post to this group, send email to:
MedicalConspiracies googlegroups.com
To unsubscribe from this group, send email to:
MedicalConspiracies-unsubscribe googlegroups.com
For more options, visit this group at:
http://groups.google.com/group/MedicalConspiracies
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤«¤»¥«¤»§«¤»¥«¤»§«
If Paranormal Research and Medical Conspiracies are of interest check out:
Paranormal_Research = Scientific Data & Health Conspiracies
To visit Paranormal_Research on the web, go to:
http://groups.yahoo.com/group/Paranormal_Research/
To subscribe to this group, send an email to:
Paranormal_Research-subscribe@yahoogroups.com
Any information here in is for educational purpose only, it may be news related, purely speculation or someone's opinion, If health related always consult with a qualified health practitioner before deciding on any course of treatment, especially for serious or life-threatening illnesses.
**COPYRIGHT NOTICE**
In accordance with Title 17 U.S.C. Section 107,
any copyrighted work in this message is distributed under fair use without profit or payment to those who have expressed a prior interest in receiving the included information for non-profit research and educational purposes only. http://www.law.cornell.edu/uscode/17/107.shtml -~----------~----~----~----~------~----~------~--~---
|